SCHEMBL29373345

SCHEMBL29373345

Cc1ccc(C(F)F)cc1C#N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.43
CYP11B1 P15538 3/20 0.37
CYP11B2 P19099 3/20 0.37
ADRB2 P07550 2/20 0.36
ADRB1 P08588 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPK1 P28482 1/20 0.36
ADRB3 P13945 1/20 0.36
LMNA P02545 1/20 0.36
TRPA1 O75762 1/20 0.35
PTGS1 P23219 1/20 0.35
CACNA1C Q13936 1/20 0.35
ALDH1A1 P00352 2/20 0.35
CACNA1H O95180 1/20 0.34
AR P10275 4/20 0.33
PGR P06401 1/20 0.33
KDM4E B2RXH2 1/20 0.33
S1PR3 Q99500 1/20 0.33
MCL1 Q07820 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5177002 0.86 LMNA (0.52) TSHRADRB2ADRB1CYP1A2CYP3A4
SCHEMBL24196660 0.84 TSHR (0.43) TSHRCYP11B1CYP11B2ARPGR
SCHEMBL16956259 0.82 TSHR (0.42) TSHRADRB2ADRB1CYP1A2CYP3A4
SCHEMBL26458011 0.78 CYP11B1 (0.36) TSHRCYP11B1CYP11B2ADRB2ADRB1
SCHEMBL30892077 0.78 CYP11B1 (0.45) TSHRCYP11B1CYP11B2ADRB2ADRB1
SCHEMBL2824439 0.78 CYP11B1 (0.45) TSHRCYP11B1CYP11B2ADRB2ADRB1
SCHEMBL16953669 0.77 TSHR (0.41) TSHRADRB2ADRB1CYP1A2CYP3A4
SCHEMBL18927428 0.77 TSHR (0.37) TSHRADRB2ADRB1CYP1A2CYP3A4
SCHEMBL16959601 0.77 TSHR (0.37) TSHRADRB2ADRB1CYP1A2CYP3A4
SCHEMBL31332331 0.76 ADRB2 (0.54) TSHRCYP11B1CYP11B2ADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220242847-A1 PYRIDINONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS AGAINST HIV INFECTED CELLS MERCK SHARP & DOHME CORP. (US) 2022-08-04 US claimed
US-20220064147-A1 PYRIMIDONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS AGAINST HIV INFECTED CELLS MERCK SHARP & DOHME CORP. (US) 2022-03-03 US claimed
CN-114026081-A Pyridone derivatives as selective cytotoxic agents against HIV-infected cells 默沙东公司 2022-02-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220064147-A1 PYRIMIDONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS AGAINST HIV INFECTED CELLS TYMP, PNP, CD4 TSHR 4499/4885CYP11B1 3424/4885CYP11B2 3482/4885
US-20220242847-A1 PYRIDINONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS AGAINST HIV INFECTED CELLS PRUNE1, G6PD, ACIN1 TSHR 4614/4885CYP11B1 2047/4885CYP11B2 2676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.